Curaleaf Holdings (CURLF) Change in Account Payables (2019 - 2024)
Curaleaf Holdings (CURLF) recorded quarterly Change in Account Payables of -$10.0 million in Q4 2024, down 111.09% quarter-over-quarter from $89.8 million in Q3 2024, and down 153.26% on a YoY basis from $18.7 million in Q1 2024.
Curaleaf Holdings (CURLF) Change in Account Payables (2019 - 2024) Analysis & Trends
Curaleaf Holdings' Change in Account Payables history runs 6 years deep, the most recent figure standing at -$10.0 million for Q4 2024.
- In Q4 2024, Change in Account Payables fell 153.26% year-over-year to -$10.0 million; the TTM figure through Dec 2024 stood at $20.7 million (down 37.46% YoY), while the FY2025 annual figure was -$5.2 million, up 7.76% from the prior year.
- Change in Account Payables was -$10.0 million for Q4 2024 at Curaleaf Holdings, down from $89.8 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $101.9 million in Q2 2024 to a low of -$10.0 million in Q4 2024.
- Historically, Change in Account Payables has averaged $29.4 million across 5 years, with a median of $17.0 million in 2020.
- The sharpest annual moves came in 2021 and 2022: Change in Account Payables tumbled 155.18% in 2021, then soared 12179.39% in 2022.
- A 5-year view of Change in Account Payables shows it stood at $15.2 million in 2020, then sank by 155.18% to -$8.4 million in 2021, then surged by 96.64% to -$282000.0 in 2022, then surged by 6726.95% to $18.7 million in 2023, then tumbled by 153.26% to -$10.0 million in 2024.
- The last three Change in Account Payables figures came in at -$10.0 million (Q4 2024), $89.8 million (Q3 2024), and $101.9 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 190,000.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 167.64 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -9.95 Mn |
| Dec 31, 2024 | -9.95 Mn |
| Sep 30, 2024 | 89.75 Mn |
| Sep 30, 2024 | 89.75 Mn |
| Jun 30, 2024 | 101.89 Mn |
| Jun 30, 2024 | 101.89 Mn |
| Dec 31, 2023 | 18.69 Mn |
| Dec 31, 2023 | 18.69 Mn |
| Sep 30, 2023 | 63.72 Mn |
| Sep 30, 2023 | 63.72 Mn |
| Jun 30, 2023 | 69.36 Mn |
| Jun 30, 2023 | 69.36 Mn |
| Dec 31, 2022 | -282,000.00 |
| Dec 31, 2022 | -282,000.00 |
| Sep 30, 2022 | 12.20 Mn |
| Sep 30, 2022 | 12.20 Mn |
| Jun 30, 2022 | 2.42 Mn |
| Jun 30, 2022 | 2.42 Mn |
| Mar 31, 2022 | 35.76 Mn |
| Mar 31, 2022 | 35.76 Mn |